TRAVERSA SERGIO (Chief Executive Officer) purchased 27.3% of their position (272.50K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $599.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/6/2025ACC: 0001213900-25-106837
DirectorOfficer· Chief Executive Officer
Since Dec 2018
+272.50K
Net shares
Net buyer
$599.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
272.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+272.50K
Price / share
$2.20
Trade value
$599.50K
% of position
27.3%
11/5/2025
1M→1.27M
Total
Net shares
+272.50K
Net value
$599.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2025 | P · Purchase | +272.50K | $2.20 | $599.50K | 27.3% | 1M | 1.27M |
| Total | +272.50K | $599.50K | ||||||
Derivative Transactions0
No derivative transactions reported